Skip to content
value.today

Precision Neuroscience Corp

🇺🇸 New York, New York, USAHealth CareFounded 2021
Total raised
$395 M
4 rounds on record
Latest round
$250 M
Sep 2026
First round on record
Apr 2021
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Precision Neuroscience Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2026$250 MNo. 4$250 million to $1 billion

Precision Neuroscience Corp: Raise no. 4, Sep 2026

Investors in this round

46 investors had bought by the notice of Sep 28, 2026: 46 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$250 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Benjamin Rapoport · Executive Officer, Director · Chief Science Officer
  • Craig Mermel · Executive Officer, Director · Chief AI and Data Officer
  • Konstantinos Alataris · Executive Officer, Director · President
  • Michael Kaswan · Executive Officer · Chief Financial Officer
  • Michael Mager · Executive Officer, Director · Chief Executive Officer
  • Howard Morgan · Director
  • Michael Goller · Director
  • Ravi Mehta · Director
  • Stephen Biggar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Kaswan, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 28, 2026. Read the notice at the SEC.

equity, optionsSEC
Oct 2024$93 MNo. 3$50 to $250 million

Precision Neuroscience Corp: Raise no. 3, Oct 2024

Investors in this round

21 investors had bought by the notice of Oct 17, 2024: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$93 M of $150 M offered; $57 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Convertible Securities Shares
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Benjamin Rapoport · Director, Executive Officer · President, Chief Science Officer
  • Craig Mermel · Director, Executive Officer · President and Chief Product Officer
  • MIchael M. Kaswan · Executive Officer · Chief Financial Officer
  • Michael Mager · Director, Executive Officer · Chief Executive Officer
  • Eric M. Attias · Director
  • Howard M. Morgan · Director
  • Jason Chen · Director
  • Ravi Mehta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Mager, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 17, 2024. Read the notice at the SEC.

equitySEC
Dec 2022$41 MNo. 2$10 to $50 million

Precision Neuroscience Corp: Raise no. 2, Dec 2022

Investors in this round

20 investors had bought by the notice of Feb 1, 2023: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$41 M of $42 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Benjamin Rapoport · Executive Officer, Director · President, Chief Science Officer and Secretary
  • Craig Mermel · Executive Officer, Director · Chief Product Officer
  • Michael Mager · Executive Officer, Director · Chief Executive Officer
  • Eric M. Attias · Director
  • Howard M. Morgan · Director
  • Jason Chen · Director
  • Ravi Mehta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Mager, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 1, 2023. Read the notice at the SEC.

equitySEC
Apr 2021$11 MNo. 1$10 to $50 million

Precision Neuroscience Corp: Raise no. 1, Apr 2021

Investors in this round

2 investors had bought by the notice of Apr 28, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $12 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Benjamin Rapoport · Executive Officer, Director · President, Chief Science Officer and Secretary
  • Michael Mager · Executive Officer, Director · Chief Executive Officer
  • Craig Mermel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Mager, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 28, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Precision Neuroscience Corp chose not to state its revenue in its newest notice of a funding round (Sep 2026).

    SEC Form D · Sep 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2026

That is all the official record says: Precision Neuroscience Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Precision Neuroscience Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 46 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Precision Neuroscience Corp
NameRoleNamed in
Benjamin RapoportChief Science OfficerSep 2026
Craig MermelChief AI and Data OfficerSep 2026
Konstantinos AlatarisPresidentSep 2026
Michael KaswanChief Financial OfficerSep 2026
Michael MagerChief Executive OfficerSep 2026
MIchael M. KaswanChief Financial OfficerOct 2024
Benjamin RapoportChief Science OfficerSep 2026
Craig MermelChief AI and Data OfficerSep 2026
Howard MorganDirectorSep 2026
Konstantinos AlatarisPresidentSep 2026
Michael GollerDirectorSep 2026
Michael MagerChief Executive OfficerSep 2026
Ravi MehtaDirectorSep 2026
Stephen BiggarDirectorSep 2026
Eric M. AttiasDirectorOct 2024
Howard M. MorganDirectorOct 2024
Jason ChenDirectorOct 2024